Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
39.13 USD | +1.45% | +1.03% | +5.82% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.82% | 4.9B | |
-2.61% | 103B | |
+1.86% | 95.28B | |
+1.46% | 22.15B | |
-15.79% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-13.09% | 16.05B | |
+4.58% | 13.68B | |
+35.27% | 12.17B |
- Stock Market
- Equities
- HALO Stock
- News Halozyme Therapeutics, Inc.
- Halozyme Therapeutics Q4 Adjusted EPS, Revenue Decline; FY2022 Guidance Reiterated